首页> 外文期刊>BMJ Open Quality >Chasing the Golden Hour – Lessons learned from improving initial neutropenic sepsis management.
【24h】

Chasing the Golden Hour – Lessons learned from improving initial neutropenic sepsis management.

机译:追逐黄金时段–改善初始中性粒细胞减少性败血症管理的经验教训。

获取原文
           

摘要

Neutropenic sepsis remains a time critical and potentially fatal complication of systemic anti-cancer therapy. A target ‘door to needle’ time of one hour for first dose empirical intravenous antibiotics continues to be promoted nationally. A baseline audit (June 2011) highlighted shortfalls in care in the Belfast Trust, with only 15% of patients receiving antibiotics within sixty minutes. A multi-professional group within the Trust was established to try and initiate the improvements in neutropenic sepsis recognition and initial management that were urgently required. A number of strategies have been developed over the last five years. Firstly an integrated care pathway was introduced, which is currently used by nursing and medical staff for patients presenting with suspected neutropenic sepsis, through acute cancer centre assessment areas and emergency departments, as well as inpatients developing neutropenic sepsis. An initial reaudit June 2012 demonstrated improvement (62% meeting 1hour target), but a subsequent audit, January 2013, was disappointing (only 50% meeting 1hour target). In response, a new compact, user-friendly care pathway was introduced. A range of other measures have also been subsequently introduced. Patients9 care is continually monitored through simple ward based documentation, completed after initial treatment of each neutropenic sepsis episode. A patient group direction facilitates nurse led prescribing and administration of first dose antibiotics. Regular multidisciplinary education sessions and improved access to regional guidelines have also been prioritised. From November 2013, consistently greater than 80% of patients have met the one hour target. Recent data continues to be encouraging; in July 2016 100% of patients received first doses within sixty minutes, in October 95% of patients. Significant sustained improvements in meeting the sixty minute target have been demonstrated. The combination of measures ensures neutropenic sepsis is considered and basic clinical care delivered quickly and safely, through a co-ordinated standardised approach, to avoid complications.
机译:中性粒细胞减少性败血症仍然是全身性抗癌治疗的时间紧迫且可能致命的并发症。全国范围内一直在推广目标目标为第一剂经验性静脉注射抗生素的“针刺门”时间为一小时。基线审核(2011年6月)强调了贝尔法斯特信托基金会的医疗服务不足,只有15%的患者在60分钟内接受了抗生素治疗。基金会内成立了一个多专业小组,以尝试并启动迫切需要的中性粒细胞减少性败血症识别和初始管理方面的改进。在过去的五年中,已经制定了许多策略。首先,引入了一种综合护理途径,护理和医护人员目前正在通过急性癌症中心评估区和急诊室,对患有中性粒细胞减少性败血症的患者以及发展中性粒细胞减少性脓毒症的患者使用该途径。 2012年6月的初次审核显示有所改善(达到1小时目标的占62%),但随后的2013年1月的审核令人失望(只有1%的目标达到1小时的目标)。因此,引入了一种新的紧凑,用户友好的护理途径。随后还采取了一系列其他措施。通过简单的病房记录对患者的护理进行持续监测,并在每次中性粒细胞减少性败血症发作的初始治疗后完成。患者组的指导有助于护士指导开处方和施用第一剂抗生素。定期的多学科教育会议和改进的获取区域准则的机会也被优先考虑。从2013年11月开始,始终有超过80%的患者达到了1小时目标。最近的数据继续令人鼓舞;在2016年7月,100%的患者在60分钟内接受了第一剂,在10月,95%的患者接受了第一剂。已经证明,在实现60分钟目标方面取得了显着的持续改进。这些措施的组合确保通过协调一致的标准化方法来考虑中性粒细胞减少症并快速安全地提供基本的临床护理以避免并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号